Fusion of the androgen-dependent TMPRSS2 gene to ETS-transcription factor ERG (TMPRSS2:ERG) is one of the most common genetic alterations in prostate cancer occurring in 50%–70% of tumors [79]. The gene discussed is ERG; the disease is prostate carcinoma.